UF Health Researcher’s Analysis Finds New Pattern of Mutations in Omicron Variant
University of Florida Health researcher has successfully analyzed the many mutations in the omicron variant of the SARS-CoV-2 virus, a crucial step in better understanding the variant’s potential threat and ways to combat it.
Patients Who Recover From Severe COVID-19 Still Have Significant Risk of Death, UF Study Finds
Patients who have recovered from severe COVID-19 have more than twice the mortality risk within the year following their illness than people... Read More
COVID-19 Spread Undetected in U.S., Europe Earlier Than Believed, Study Shows, Offering Lessons for Future Outbreaks, Including Transmission of Omicron Variant
Local COVID-19 transmission was underway in California, New York, Florida, and Texas well before the first reported U.S. case in Washington state on Jan. 20, 2020, according to a new study published in Nature, which indicates the virus spread much earlier and faster in the United States and Europe than previously thought.
Oragenics Announces Positive COVID-19 Challenge Study Results Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
UF startup and Sid Martin Biotech alumni company Oragenics, Inc. announced the results from its study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study. The study provided preclinical data for formulations designed for both intranasal and intramuscular administration.
Two Common Compounds Show Effectiveness Against COVID-19 Virus in Early Testing
A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida Health researchers have found.
UF’s COVID Restore Clinic Treats Long Haulers
Dr. Irene Estores, medical director of the Integrative Medicine Program at UF leads the COVID Restore Clinic to treat long haulers. According to the WHO definition, long COVID “occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis.”
UF Health Scientists Develop Novel Method of Cryopreserving Lung Tissue for COVID-19 Research
A team of University of Florida Health researchers have developed a method to cryopreserve lung tissue at minus-184 degrees Fahrenheit that give scientists an important new tool to study how the coronavirus infects individuals.
UF Health Psychiatrist Talks About the Mental Health Challenges Posed by COVID-19
Jacqueline Hobbs, M.D., Ph.D., an associate professor in the University of Florida College of Medicine’s department of psychiatry, discusses the burden of coping with the stress caused by the upheaval of normal life and the need to pay closer attention to our mental well-being.
UF Health Expert Discusses COVID-19 Booster Shots
Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose.
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of Its SARS-CoV-2 Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced the initiation of a study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study.